Clin2
NCT07777133Worth exploringNot yet recruiting

Study of how an experimental drug leaves the body in healthy women

Healthy Female Participants

This study looks at how the experimental drug navlimetostat is processed and removed from the body in healthy women. It helps researchers understand the drug's effects before it is tested in patients.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
6 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are a healthy woman, aged 45 or older, and have reached menopause or had surgery to prevent pregnancy.
  • Your body mass index (BMI) is between 18 and 35.
  • You have regular bowel movements (at least once every two days).
  • You do not have any significant ongoing medical conditions or recent stomach or bowel problems.
  • You do not have a history of unusual bleeding or easy bruising.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07773129Recruiting· Phase 1
How a new drug is processed in healthy men

This study tests a new drug called ASP3082 to see how the body absorbs, distributes, and removes it. It is for healthy men only and will help researchers understand the drug's behavior before it is tested in patients.

Madison, Wisconsin
NCT07867327Not yet recruiting· Phase 1
A study of a new drug in healthy men

This trial tests whether a new drug is safe in healthy men. It is a ''first-in-human'' study, so it helps determine the right dose and check for side effects.

Madison, Wisconsin
NCT07544628Recruiting· Phase 1
Safety Study of Navlimetostat Tablet in Healthy Women

This is an early-stage safety study testing a new tablet form of navlimetostat in healthy adult women. The goal is to understand how the body processes this drug and make sure it is safe and well-tolerated.

Decatur, Georgia
NCT07800897Recruiting· Phase 1
How a new drug reacts with food and other medicines in healthy women

This trial checks how a new experimental drug (called Navlimetostat) interacts with other medicines and how food affects it. Healthy women participate to help researchers find the right dose and safety, which could later help people with cancer.

Québec, Quebec
NCT07334262Not yet recruiting· Phase 1
How food and the body process the study drug in healthy adults

This early-stage study in healthy volunteers looks at how a new experimental medication (RNK08954) is processed in the body, including how food affects its absorption and how it is eliminated. Participation involves staying at a clinic, eating standard meals, and providing blood and urine samples.

Shanghai
NCT07674940Recruiting· Phase 1
Study of a new drug at different doses in healthy people

This trial tests different doses of a new study drug in healthy people to see how safe it is and how the body handles it. Participation involves taking the drug and having regular check-ups.

Miramar, Florida

Hear when a new Healthy Female Participants trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.